Form 4 for INSM INSMED Inc
Accepted 2025-01-10 00:00:00 ET · period of report 2025-01-07 · accession 0001628280-25-001206 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-10 | 2025-01-07+ | INSM | Bonstein Sara | CFO | S - Sale | $65.43 | -6,000 | 118.9K | -5% | -$392.6K |
| D | 2025-01-10 | 2025-01-08 | INSM | Bonstein Sara | CFO | A - Grant | — | +6,657 | 119.9K | +6% | — |
| D | 2025-01-10 | 2025-01-08 | INSM | Bonstein Sara | CFO | A - Grant | $0.00 | +31.9K | 31.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-08 | S | D | 1,464 | $66.05 | 113,272 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-07 | S | D | 3,470 | $65.70 | 114,736 | D | — | — | (F2) This is the weighted average sales price representing 3,470 shares sold at prices ranging from $65.69 to $65.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. (F3) Includes 725 shares acquired through the Company's 2018 Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2025-01-08 | A | A | 6,657 | — | 119,929 | D | — | — | (F4) Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. (F5) Each RSU was granted on January 8, 2025 for no consideration. |
| 4 | Common | Common Stock | 2025-01-10 | S | D | 1,066 | $63.72 | 118,863 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2025-01-08 | A | A | 31,930 | $0.00 | 31,930 | D | $65.72 · — to 2035-01-08 | 31,930 Common Stock | (F6) These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. |